Crossmark

The importance of clinician, patient and researcher collaborations in Alport syndrome

Crossref DOI link: https://doi.org/10.1007/s00467-019-04241-7

Published Online: 2019-05-01

Published Print: 2020-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rheault, Michelle N.

Savige, Judith

Randles, Michael J.

Weinstock, André

Stepney, Melissa

Turner, A Neil

Parziale, Gina

Gross, Oliver

Flinter, Frances A

Miner, Jeffrey H

Lagas, Sharon

Gear, Susie

Lennon, Rachel https://orcid.org/0000-0001-6400-0227
Funding

Funding for this research was provided by:

Wellcome Trust (203128/Z/16/Z, 202860/Z/16/Z)

Kidney Research UK (K1199)
License Information

Text and Data Mining valid from 2019-05-01
More Information

Article History

Received: 24 February 2019

Accepted: 15 March 2019

First Online: 1 May 2019

Compliance with ethical standards

:

: MR receives research funding from Regulus Therapeutics and Reata Pharmaceuticals. The other authors declare no conflicts of interests.